Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2026 10:44 ET | Source: PolTREG S.A.

PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes

The European Medicines Agency (EMA) has officially qualified PolTREG to submit an application for marketing authorization in the European Union for the PolTREG-T1D cell preparation. GDAŃSK, Poland,...
March 09, 2026 08:00 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer

Closing of additional $50 million tranche of $100 million equity private placement after achievement of clinical milestone for rondecabtagene autoleucelSmital Shah appointed Chief Financial and...
March 05, 2026 07:00 ET | Source: https://immatics.com/

Immatics Announces Full Year 2025 Financial Results and Business Update

Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug...
March 02, 2026 04:01 ET | Source: Research and Markets

$14+ Bn Cell Therapy Manufacturing Market Trends and Forecasts, 2035 - Researchers are Exploring Over 1,000 Cell and Gene Therapy Candidates Targeting a Wide Range of Disease Indications

Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market (7th Edition): Trends and Forecast Till 2035 - Distribution by Type of Cell Therapy, Source of Cells, Scale of...
February 26, 2026 10:29 ET | Source: Research and Markets

Cell & Gene Therapy Drug Delivery Devices Market - Global Forecast Report 2026-2032: Ongoing Innovation in Vector Engineering, Biologic Manufacturing, and the Expansion of Point-of-care Capabilities

Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapy Drug Delivery Devices Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. In...
February 24, 2026 09:00 ET | Source: Human Continuum Inc.

Human Continuum Appoints Dr. Michael Milligan, MD, MBA, as its Chief Medical Officer to Oversee Innovative Applications for Next-Generation Extracellular Vesicle Therapeutics

New York, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...
February 24, 2026 07:00 ET | Source: Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates

~30% Quarterly Revenue Growth Driven by Amtagvi Demand Gross Margin Increased to 50% FY25 Revenue of $264M Achieved Annual Guidance U.S. FDA Fast Track Designation Granted for Lifileucel in...
February 23, 2026 08:00 ET | Source: Alps Group Inc

Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol

KUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the “Company” or “Alps Group”), the parent company of Alps Life Sciences Inc. (“Alps Holdco”), a fully integrated...
February 23, 2026 08:00 ET | Source: Lyell Immunopharma, Inc

Lyell Immunopharma Announces Participation in March Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen receptor...
February 20, 2026 07:16 ET | Source: Research and Markets

State of the Life Sciences Industry, Q4 2025 Review - Unveils Key Trends and Opportunities in Pharma, Biopharma, Medical Devices, Cell Biology

Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "State of the Life Sciences Industry - Fourth Quarter Review" has been added to ResearchAndMarkets.com's offering. The latest quarterly research...